Just three months after an authoritative epidemiological study found that PSA screenings for prostate cancer are likely to do more harm than good, an influential group that provides guidance to doctors, insurance companies and policy makers has tossed its commitment to breast cancer screenings for women under 50 in the trash.The New York Times and just about every other paper reports on the big switch, which is founded on evidence that too many tests have led to too many treatments of too many cancers that would have done little harm if left alone, but whose treatment seriously damaged quality of life.
Read more about the new ideas about mammograms in the New York Times.
